Last reviewed · How we verify
NCT04477213
Risk Profiling of the Occupational Exposure of COVID-19 to Healthcare Workers.
trial in COVID19 in 286 participants. Completed in 2 October 2021.
30 September 2021
Quick facts
| Lead sponsor | NMC Specialty Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 286 |
| Start date | 11 September 2021 |
| Primary completion | 30 September 2021 |
| Estimated completion | 2 October 2021 |
| Sites | 1 location across United Arab Emirates |
Conditions studied
- COVID19 — all drugs for COVID19 →
- Healthcare Workers — all drugs for Healthcare Workers →
Sponsor
NMC Specialty Hospital
Who can join
Adults 18 to 70, any sex, with COVID19 or Healthcare Workers. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators propose to conduct a retrospective study to define and quantify the variable occupational and non-occupational risk among various HCWs who got COVID-19 . The investigators aim to determine the rates of acquisition of COVID-19, in the context of level of exposure , adequacy of PPE use and other infection control measuresrecommended for COVID-19 and also to define the risk of secondary disease transmission to other household members of HCWs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04477213
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID19
Currently open trials in the same condition.
- NCT07337382 — The Optimising Isolation, Quarantine and Distancing Study for COVID-19 · active not recruiting
- NCT04376034 — Convalescent Plasma Collection and Treatment in Pediatrics and Adults · Phase 3 · recruiting
- NCT04367883 — Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection · recruiting
Other NMC Specialty Hospital trials
Trials by the same sponsor.
- NCT06159465 — Utility of Defining ARDS and Past and Current Definitions of ARDS · completed
- NCT05550181 — Intraoperative Hypocapnia in PROVHILO and PROBESE · completed
- NCT05347888 — How Well do we Feed the Critically Ill Patients · completed
- NCT04998799 — Practice Variation on Antithrombotics in COVID-19 · completed
- NCT04665960 — Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04477213 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NMC Specialty Hospital
- Last refreshed: 11 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04477213.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing